Literature DB >> 29156980

Platelet-Rich Plasma and Hyaluronic Acid Are Not Synergistic When Used as Biological Adjuncts with Autologous Osteochondral Transplantation.

Niall A Smyth1, Keir A Ross2, Amgad M Haleem3, Charles P Hannon4, Christopher D Murawski5, Huong T Do6, John G Kennedy6.   

Abstract

Introduction Autologous osteochondral transplantation (AOT) is a treatment for osteochondral lesions with known concerns, including histological degradation of the graft and poor cartilage integration. Platelet-rich plasma (PRP) and hyaluronic acid (HA) have been described has having the potential to improve results. The aim of this study was to evaluate the effect of PRP and HA on AOT in a rabbit model. Methods Thirty-six rabbits underwent bilateral knee AOT treated with either the biological adjunct (PRP, n = 12; HA, n = 12; PRP + HA, n = 12) or saline (control). PRP and HA were administered as an intra-articular injection. The rabbits were euthanized at 3, 6, or 12 weeks postoperatively. The graft sections were assessed using the modified International Cartilage Repair Society (ICRS) scoring system. The results from the PRP alone group is from previously published data. Results The mean modified ICRS histological score for the PRP-treated group was higher than its control ( P = 0.002). The mean modified ICRS histological score for the HA-treated group showed no difference compared with its control ( P = 0.142). The mean modified ICRS histological score for the PRP + HA-treated group was higher than its control ( P = 0.006). There was no difference between the mean modified ICRS scores of the PRP- and the PRP + HA-treated grafts ( P = 0.445). Conclusion PRP may decrease graft degradation and improve chondral integration in an animal model. In this model, the addition of HA was not synergistic for the parameters assessed. LEVEL OF EVIDENCE: Basic science, Level V. CLINICAL RELEVANCE: PRP can be used as an adjunct to AOT, which may decrease graft degeneration and improve clinical outcomes. HA may not influence AOT.

Entities:  

Keywords:  animal models; articular cartilage; cartilage repair; tissue

Mesh:

Substances:

Year:  2017        PMID: 29156980      PMCID: PMC6042028          DOI: 10.1177/1947603517690022

Source DB:  PubMed          Journal:  Cartilage        ISSN: 1947-6035            Impact factor:   4.634


  59 in total

1.  Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes.

Authors:  Adriano Spreafico; Federico Chellini; Bruno Frediani; Giulia Bernardini; Silvia Niccolini; Tommaso Serchi; Giulia Collodel; Alessandro Paffetti; Vittorio Fossombroni; Mauro Galeazzi; Roberto Marcolongo; Annalisa Santucci
Journal:  J Cell Biochem       Date:  2009-12-01       Impact factor: 4.429

2.  The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy.

Authors:  Hillary J Braun; Hyeon Joo Kim; Constance R Chu; Jason L Dragoo
Journal:  Am J Sports Med       Date:  2014-03-14       Impact factor: 6.202

3.  Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems.

Authors:  Tiffany N Castillo; Michael A Pouliot; Hyeon Joo Kim; Jason L Dragoo
Journal:  Am J Sports Med       Date:  2010-11-04       Impact factor: 6.202

4.  Outcome of osteochondral autograft transplantation for type-V cystic osteochondral lesions of the talus.

Authors:  P E Scranton; C C Frey; K S Feder
Journal:  J Bone Joint Surg Br       Date:  2006-05

5.  The effect of platelet-rich plasma on autologous osteochondral transplantation: an in vivo rabbit model.

Authors:  Niall A Smyth; Amgad M Haleem; Christopher D Murawski; Huong T Do; Jonathan T Deland; John G Kennedy
Journal:  J Bone Joint Surg Am       Date:  2013-12-18       Impact factor: 5.284

6.  Cartilage and bone markers and inflammatory cytokines are increased in synovial fluid in the acute phase of knee injury (hemarthrosis)--a cross-sectional analysis.

Authors:  P Swärd; R Frobell; M Englund; H Roos; A Struglics
Journal:  Osteoarthritis Cartilage       Date:  2012-08-05       Impact factor: 6.576

7.  Effect of impact on chondrocyte viability during insertion of human osteochondral grafts.

Authors:  Boris H Borazjani; Albert C Chen; Won C Bae; Shantanu Patil; Robert L Sah; Gary S Firestein; William D Bugbee
Journal:  J Bone Joint Surg Am       Date:  2006-09       Impact factor: 5.284

8.  Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis.

Authors:  D D Greenberg; A Stoker; S Kane; M Cockrell; J L Cook
Journal:  Osteoarthritis Cartilage       Date:  2006-04-17       Impact factor: 6.576

9.  Demineralized bone matrix and platelet-rich plasma do not improve healing of osteochondral defects of the talus: an experimental goat study.

Authors:  C J A van Bergen; G M M J Kerkhoffs; M Özdemir; C M Korstjens; V Everts; L J van Ruijven; C N van Dijk; L Blankevoort
Journal:  Osteoarthritis Cartilage       Date:  2013-07-27       Impact factor: 6.576

10.  Evaluation of subsidence, chondrocyte survival and graft incorporation following autologous osteochondral transplantation.

Authors:  Niels B Kock; Gerjon Hannink; Albert van Kampen; Nico Verdonschot; Job L C van Susante; Pieter Buma
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-09-09       Impact factor: 4.342

View more
  2 in total

1.  Modernizing Storage Conditions for Fresh Osteochondral Allografts by Optimizing Viability at Physiologic Temperatures and Conditions.

Authors:  Janet M Denbeigh; Mario Hevesi; Carlo A Paggi; Zachary T Resch; Leila Bagheri; Kristin Mara; Arvin Arani; Chenghao Zhang; A Noelle Larson; Daniel B F Saris; Aaron J Krych; Andre J van Wijnen
Journal:  Cartilage       Date:  2019-11-28       Impact factor: 3.117

2.  Hyaluronic Acid Influence on Normal and Osteoarthritic Tissue-Engineered Cartilage.

Authors:  Shabnam Hemmati-Sadeghi; Jochen Ringe; Tilo Dehne; Rainer Haag; Michael Sittinger
Journal:  Int J Mol Sci       Date:  2018-05-19       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.